Mick has not only overseen ResMed’s transformation from a medical device leader to a global pioneer and leader in digital health, he and his team’s collective mission is to help the 936 million people who suffocate every night from the effects of sleep apnea, and the 400 million people with C-O-P-D, live higher-quality happier lives with the help of ResMed’s medical device and digital health technologies Plus ResMed powered through the pandemic with four straight quarters of double-digit revenue and earnings gains, topping consensus estimates every quarter. Since Farrell became CEO five years ago, revenue has doubled to $3 billion and ResMed’s stock is up roughly 300%. That far outpaces the S&P 500’s 116% rise in that time. He leads a global company agile enough to shift during a global pandemic and help give hundreds of thousands of people a fighting chance against COVID-19, all while keeping 7,500 employees safe and working in San Diego and around the world. ResMed, a top-5 global producer of hospital-to-home ventilators, quickly responded to the unprecedented global demand for critical life-saving ventilators and bi-level devices triggered by the pandemic. Between January and July, the company produced more than 150,000 ventilators — more than 3.5 times its output over the period in the previous year — giving the gift of “breath” to people fighting the virus.
